Dr Reddys Laboratories Ltd

NSE :DRREDDY BSE :500124 Sector : Pharmaceuticals

Buy, Sell or Hold DRREDDY? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

22 Mar
4474.95
(1.26%)

21 Mar
4419.35
(-0.45%)

20 Mar
4439.45
(0.07%)

17 Mar
4436.15
(1.20%)

16 Mar
4383.75
(-0.24%)

15 Mar
4394.50
(1.03%)

14 Mar
4349.55
(-0.48%)

13 Mar
4370.40
(-0.57%)

10 Mar
4395.55
(0.33%)

09 Mar
4380.95
(-1.02%)

08 Mar
4426.25
(-0.29%)

06 Mar
4439.20
(0.03%)

03 Mar
4437.95
(1.08%)

02 Mar
4390.60
(1.07%)

01 Mar
4344.20
(0.64%)

28 Feb
4316.60
(-2.36%)

27 Feb
4421.00
(-1.56%)

24 Feb
4491.10
(0.93%)

23 Feb
4449.60
(-0.61%)

22 Feb
4476.70
(-0.21%)

21 Feb
4486.15
(0.25%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bullish

Medium Term Investors

Very Bullish

Long Term Investors

Very Bullish

Moving Averages

5 DMA

Bullish

4431.02

10 DMA

Bullish

4406.32

20 DMA

Bullish

4412.53

50 DMA

Bullish

4396.85

100 DMA

Bullish

4398.66

200 DMA

Bullish

4344.17

Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Mar 22, 2023 04:00 PM For Next Trading Session

Pivots	Classic	Fibonacci	Camarilla	Woodie	DM
R3	4562.16	4521.08	4492.59	-	-
R2	4521.08	4496.57	4486.71	4525.59	-
R1	4498.01	4481.44	4480.83	4507.03	4509.55
P	4456.93	4456.93	4456.93	4461.44	4462.7
S1	4433.86	4432.42	4469.07	4442.88	4445.4
S2	4392.78	4417.29	4463.19	4397.29	-
S3	4369.71	4392.78	4457.31	-	-

Key Metrics

EPS

141.72

P/E

31.58

P/B

3.87

Dividend Yield

0.67%

Market Cap

74,520 Cr.

Face Value

5

Book Value

1156.21

ROE

11.84%

EBITDA Growth

2,002.2 Cr.

Debt/Equity

0.17

Shareholding Pattern

	26.7%	Total Promoter Holding

	10.94%	Mutual Fund Holdings

	27.29%	FIIs

	11.84%	Non Institution

	12.22%	Insurance Companies

	0.25%	Custodians

	10.76%	Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)

Consolidated
Standalone

Dr Reddys Laboratories Ltd Quaterly Results

	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022
INCOME	5412.6	5607.3	6096.2	6386.6	6854.5
PROFIT	709.3	97	1189	1114.2	1243.9
EPS	42.75	5.84	71.64	67.13	74.91

Dr Reddys Laboratories Ltd Quaterly Results

	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022
INCOME	3542.6	3783.4	4034	4998.3	3949
PROFIT	341.1	419.7	499.5	1116.3	324.6
EPS	20.55	25.29	30.1	67.25	19.54

Profit & Loss (Figures in Rs. Crores)

Consolidated
Standalone

Dr Reddys Laboratories Ltd Profit & Loss

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
INCOME	12151	13904.6	15353.2	15959	14490.9	14477.7	16104.9	18170	20177.4	22453.8
PROFIT	1514.4	1945.62	2291.79	2071.62	1252.3	892.34	1849.63	2030.35	1954.44	2110.85
EPS	87.37	112.29	133.04	123.55	75.83	54.96	117.47	121.9	117.28	131.16

Dr Reddys Laboratories Ltd Profit & Loss

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
INCOME	8612.7	10050.1	10262.7	10645.6	10309.1	9614.9	10797.9	12693.5	14545.8	15276.8
PROFIT	1251.28	1926.89	1634.01	1320.26	1406.23	536.19	1274.22	2948.85	1849.38	1628.89
EPS	71.98	113.56	94.48	80.56	83.48	34.15	76.95	176.76	131.39	97.55

Balance Sheet (Figures in Rs. Crores)

Consolidated
Standalone

	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
SOURCES OF FUNDS :
Share Capital	83.2	83.2	83.1	83	83	82.9	85.3	85.2	85.1	84.9
Reserves Total	19,289.3	17,755.2	15,616.3	13,994.1	12,488.6	12,179.2	12,484.5	9,767.9	7,780.1	6,284.2
Equity Application Money	-160.1	-196.7	-100.6	-53.5	0	0	0	0	0	0
Total Shareholders Funds	19,212.4	17,641.7	15,598.8	14,023.6	12,571.6	12,262.1	12,569.8	9,853.1	7,865.2	6,369.1
Secured Loans	0	0	178.7	60.9	69.3	70.7	85.7	86.2	104.7	88.2
Unsecured Loans	3,384.5	3,030.8	2,031.5	3,777.2	5,002.1	4,847.8	3,266.4	4,227.9	4,372.3	3,594
Total Debt	3,384.5	3,030.8	2,210.2	3,838.1	5,071.4	4,918.5	3,352.1	4,314.1	4,477	3,682.2
Other Liabilities	192.7	212.5	280	297.4	375	427.6	344.5	351.2	174.4	86.4
Total Liabilities	22,789.6	20,885	18,089	18,159.1	18,018	17,608.2	16,266.4	14,518.4	12,516.6	10,137.7
APPLICATION OF FUNDS :
Gross Block	19,786.1	18,555.7	16,108.2	14,998.6	17,436.3	15,932.4	15,019.7	12,573.6	11,917.6	10,089.4
Less: Accumulated Depreciation	11,664.6	10,350	9,257.9	7,807.6	10,468.3	9,001.7	8,456.7	7,196.6	7,276.8	6,038.8
Net Block	8,121.5	8,205.7	6,850.3	7,191	6,968	6,930.7	6,563	5,377	4,640.8	4,050.6
Capital Work in Progress	1,293.4	1,565.1	1,535.1	2,933.5	3,470.5	3,324.5	772.2	529	638.8	565.3
Investments	2,615.9	2,211.8	2,677.8	2,587.1	2,298.3	2,109.7	3,833.1	2,247.8	1,066.8	197
Inventories	5,088.4	4,541.2	3,506.7	3,357.9	2,908.9	2,852.8	2,557.9	2,569.9	2,418.8	2,170.7
Sundry Debtors	6,676.4	4,964.1	5,027.8	3,986.9	4,052.7	3,798.6	4,125	4,101.2	3,325.3	3,180.4
Cash and Bank Balance	2,419.2	2,078.8	205.3	222.8	263.8	386.5	492.1	1,872.4	2,300.6	2,017.1
Loans and Advances	1,581	1,587.7	1,490.6	1,289.6	1,440	1,218.7	1,115.6	1,231	1,214.6	961.9
Total Current Assets	15,765	13,171.8	10,230.4	8,857.2	8,665.4	8,256.6	8,290.6	9,774.5	9,259.3	8,330.1
Current Liabilities	5,825.1	5,062.6	4,610.2	3,762.2	3,739.6	3,385.6	3,304.6	2,794.8	2,573.2	2,568.4
Provisions	1,130.8	640.3	524.1	497	591.7	660.7	759.4	1,143.9	815.7	674.1
Total Current Liabilities & Provisions	6,955.9	5,702.9	5,134.3	4,259.2	4,331.3	4,046.3	4,064	3,938.7	3,388.9	3,242.5
Net Current Assets	8,809.1	7,468.9	5,096.1	4,598	4,334.1	4,210.3	4,226.6	5,835.8	5,870.4	5,087.6
Deferred Tax Assets	1,277	1,068.6	1,219.9	431.7	540.5	678.4	590.5	260.5	191.7	174.2
Deferred Tax Liability	1.4	28.9	2	47.3	195	162	53.7	156.2	124.1	107
Net Deferred Tax	1,275.6	1,039.7	1,217.9	384.4	345.5	516.4	536.8	104.3	67.6	67.2
Other Assets	674.1	393.8	711.8	465.1	601.6	516.6	334.7	424.5	232.2	170
Total Assets	22,789.6	20,885	18,089	18,159.1	18,018	17,608.2	16,266.4	14,518.4	12,516.6	10,137.7
Contingent Liabilities	0	0	0	138	277.57	102.17	92.17	190	221.6	112.6

	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
SOURCES OF FUNDS :
Share Capital	83.2	83.2	83.1	83	83	82.9	85.3	85.2	85.1	84.9
Reserves Total	18,413.1	17,097.2	15,209.4	12,654.6	11,724.8	11,517.7	11,993.1	10,548.8	9,243.9	7,698.5
Equity Application Money	-160.1	-196.7	-100.6	-53.5	0	0	0	0	0	0
Total Shareholders Funds	18,336.2	16,983.7	15,191.9	12,684.1	11,807.8	11,600.6	12,078.4	10,634	9,329	7,783.4
Secured Loans	0	0	19.3	0	0	0	0.9	1.4	1.7	4.7
Unsecured Loans	2,205.4	1,214.5	1,437.6	1,064.6	2,588.8	2,355.2	3,084.2	3,124.7	2,664.5	2,095.3
Total Debt	2,205.4	1,214.5	1,456.9	1,064.6	2,588.8	2,355.2	3,085.1	3,126.1	2,666.2	2,100
Other Liabilities	94.6	67.9	84.1	83.2	84.6	103.4	123.6	75.3	38.2	32.6
Total Liabilities	20,636.2	18,266.1	16,732.9	13,831.9	14,481.2	14,059.2	15,287.1	13,835.4	12,033.4	9,916
APPLICATION OF FUNDS :
Gross Block	13,349.1	12,345	10,215.9	9,774.1	9,223.6	8,675.4	7,580	5,815.6	4,899.7	4,208.7
Less : Accumulated Depreciation	7,198.6	6,500.7	5,782	5,091.4	4,506.3	3,833.3	3,141.9	2,566.2	2,151.4	1,821.7
Net Block	6,150.5	5,844.3	4,433.9	4,682.7	4,717.3	4,842.1	4,438.1	3,249.4	2,748.3	2,387
Capital Work in Progress	1,200.3	900.8	411.8	400.1	675	540	616.1	488.3	576.1	423.2
Investments	4,936.7	4,649.2	5,485.5	3,933.5	3,636.5	3,101.9	5,076.1	3,862.3	2,806.5	2,379.2
Inventories	3,347.8	2,819.7	2,190.4	2,015.6	1,856.8	1,809.7	1,699.6	1,723.3	1,592.1	1,526.5
Sundry Debtors	4,945.4	4,080	4,638.7	3,717.7	4,203.8	4,405.4	3,889.5	4,711.7	4,561.5	2,963.9
Cash and Bank Balance	2,030.5	1,646.5	39.2	113.2	120.7	66.8	202.1	901.4	665.1	919.1
Loans and Advances	1,247.5	1,141	1,120	972.3	1,174.4	1,012.8	1,121.9	964.7	1,022.7	994.1
Total Current Assets	11,571.2	9,687.2	7,988.3	6,818.8	7,355.7	7,294.7	6,913.1	8,301.1	7,841.4	6,403.6
Current Liabilities	3,537.2	3,064.8	2,535.6	2,175.4	2,445.7	2,179.6	2,127.5	1,952.1	1,870	1,558
Provisions	322.2	298.7	207.3	184.7	173.4	208.4	170.6	539.5	479.5	421.4
Total Current Liabilities & Provisions	3,859.4	3,363.5	2,742.9	2,360.1	2,619.1	2,388	2,298.1	2,491.6	2,349.5	1,979.4
Net Current Assets	7,711.8	6,323.7	5,245.4	4,458.7	4,736.6	4,906.7	4,615	5,809.5	5,491.9	4,424.2
Deferred Tax Assets	440.7	582.1	867.3	214.1	346.5	382.8	306	35.7	23.1	32.5
Deferred Tax Liability	421.3	327.3	254.4	269.6	253.4	300.7	242.5	164.7	148.3	126.2
Net Deferred Tax	19.4	254.8	612.9	-55.5	93.1	82.1	63.5	-129	-125.2	-93.7
Other Assets	617.5	293.3	543.4	412.4	622.7	586.4	478.3	554.9	535.8	396.1
Total Assets	20,636.2	18,266.1	16,732.9	13,831.9	14,481.2	14,059.2	15,287.1	13,835.4	12,033.4	9,916
Contingent Liabilities	0	0	0	316.2	305.37	102.17	92.17	1,231.9	1,605.2	1,740

Cash Flow (Figures in Rs. Crores)

Consolidated
Standalone

Cash from Operating Activity 2,810.8

Net Profit before Tax and Extr...	3,061.4
Depreciation	1,165.2
Interest (Net)	-0.7
P/L on Sales of Assets	-111.9
Prov. and W/O (Net)	937.4
P/L in Forex	-75.8
Total Adjustments (PBT and Ext...	1,875.4
Operating Profit before Workin...	4,936.8
Trade and 0ther Receivables	-1,701.2
Inventories	-532.8
Trade Payables	441.2
Total Adjustments (OP before W...	-1,382.3
Cash Generated from/(used in) ...	3,554.5
Direct Taxes Paid	-743.7
Total Adjustments(Cash Generat...	-743.7
Cash Flow before Extraordinary...	2,810.8
Net Cash from Operating Activi...	2,810.8

Cash from Investing Activity -2,565.4

Purchased of Fixed Assets	-438.9
Sale of Fixed Assets	331.6
Purchase of Investments	-8,897.2
Sale of Investments	7,777.1
Interest Received	87.3
Net Cash used in Investing Act...	-2,565.4

Cash from Financing Activity -242.2

Proceeds from Issue of shares ...	33.4
Proceed from Short Tem Borrowi...	352
Of Financial Liabilities	-78.5
Dividend Paid	-414.6
Interest Paid	-134.5
Net Cash used in Financing Act...	-242.2

Cash from Operating Activity 1,338.7

Net Profit before Tax and Extr...	2,223.8
Depreciation	814.3
Interest (Net)	-128.9
P/L on Sales of Assets	7.8
Prov. and W/O (Net)	16.3
P/L in Forex	-162.3
Total Adjustments (PBT and Ext...	583.1
Operating Profit before Workin...	2,806.9
Trade and 0ther Receivables	-865.5
Inventories	-528.1
Trade Payables	329.8
Total Adjustments (OP before W...	-979.4
Cash Generated from/(used in) ...	1,827.5
Direct Taxes Paid	-488.8
Total Adjustments(Cash Generat...	-488.8
Cash Flow before Extraordinary...	1,338.7
Net Cash from Operating Activi...	1,338.7

Cash from Investing Activity -1,990.1

Purchased of Fixed Assets	-1,365.6
Sale of Fixed Assets	9.4
Purchase of Investments	-9,111.8
Sale of Investments	8,272.6
Interest Received	157.4
Net Cash used in Investing Act...	-1,990.1

Cash from Financing Activity 505.5

Proceeds from Issue of shares ...	33.4
Proceed from Short Tem Borrowi...	968.3
Of Financial Liabilities	-17.2
Dividend Paid	-414.6
Interest Paid	-64.4
Net Cash used in Financing Act...	505.5

Dr Reddys Laboratories News

Company Details

Registered Office
Address	8-2-337 Road No 3, Banjara Hills
City	Hyderabad
State	Telangana
Pin Code	500034
Tel. No.	91-40-49002900
Fax. No.	91-40-49002999
Email	shares@drreddys.com
Internet	http://www.drreddys.com

Registrars
Address	8-2-337 Road No 3
City	Hyderabad
State	Telangana
Pin Code	500034
Tel. No.	91-40-49002900
Fax. No.	91-40-49002999
Email	shares@drreddys.com
Internet	http://www.drreddys.com

Management
Name	Designation
G V Prasad	Co-Chairman & Managing Directo
K Satish Reddy	Chairman
Kalpana Morparia	Independent Director
Bruce L A Carter	Independent Director
Sridar Iyengar	Independent Director
Shikha Sanjaya Sharma	Independent Director
Leo Puri	Independent Director
K P Krishnan	Independent Director
Pennv Wan	Independent Director
K Randhir Singh	Company Sec. & Compli. Officer

Related Links

Dr Reddys Laboratories Ltd Historical Data

Dr Reddys Laboratories Ltd Technical Chart

Top Stocks - Pharmaceuticals

MARKET TODAY

PRODUCTS

SUPPORT

LEGAL & PRIVACY

MAGAZINES

Stocks: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Data is a real-time snapshot *Data is delayed by at least 15 minutes. StockFact, Market Action Data and Analysis. Data Provider CMOTS Infotech.

Disclaimer : There is no guarantee of profits or no exceptions from losses. The investment advice provided is solely the personal views of the research team. Equitypandit will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Therefore, Equitypandit doesn't bear any responsibility for any trading losses you might incur as a result of using this data.

@2023 -Equitypandit Media Corp. All Right Reserved.